The expression of Dishevelled-3 and glutamine metabolism in malignant pleural mesothelioma

Journal of Clinical Pathology

Volumn 65, Issue 9, 2012, Pages 855-858

  Li, Tong ^a,b   Hou, Sheng Cai ^b   Mao, Jian Hua ^c   Wang, Yu Cheng ^a   Lu, Xiao Dan ^d,e   Tan, Jia Li ^e,f   You, Bin ^b   Liu, Yu Ping ^b   Ni, Jian ^a,g   Au, Alfred ^h   Jablons, David M ^a   Xu, Zhidong ^a   You, Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^d NORTHEAST NORMAL UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^g TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DISHEVELLED 3 PROTEIN; DISHEVELLED PROTEIN; EXCITATORY AMINO ACID TRANSPORTER 1; GLUTAMATE AMMONIA LIGASE; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURVIVAL TIME;

EID: 85027930336     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/JCLINPATH-2011-200628     Document Type: Letter

References (8)

1. Yang H, Testa JR, Carbone M. Mesothelioma epidemiology, carcinogenesis, and pathogenesis. Curr Treat Options Oncol 2008;9:147-57. Review.
2. Sokol SY. Analysis of Dishevelled signalling pathways during Xenopus development. Curr Biol 1996;6:1456-67.
3. Uematsu K, Kanazawa S, You L, et al. Wnt pathway activation in mesothelioma: evidence of Dishevelled overexpression and transcriptional activity of beta-catenin. Cancer Res 2003;63:4547-51.
4. Amara SG, Fontana AC. Excitatory amino acid transporters: keeping up with glutamate. Neurochem Int 2002;41:313-18.
5. Pissimissis N, Papageorgiou E, Lembessis P, et al. The glutamatergic system expression in human PC-3 and LNCaP prostate cancer cells. Anticancer Res 2009;29:371-7.
6. Martinez-Hernandez A, Bell KP, Norenberg MD. Glutamine synthetase: glial localization in brain. Science 1977;195:1356-8.
7. Li T, Li H, Wang Y, et al. The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma. J Pathol 2011;223:519-30.
8. Cadoret A, Ovejero C, Terris B, et al. New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism. Oncogene 2002;21:8293-301.